O'Shaughnessy Asset Management’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-1,682
Closed -$36K 2105
2021
Q3
$36K Hold
1,682
﹤0.01% 1768
2021
Q2
$49K Buy
+1,682
New +$45.5K ﹤0.01% 1582
2020
Q1
Sell
-101
Closed -$3K 1668
2019
Q4
$3K Buy
+101
New +$2.34K ﹤0.01% 1597
2018
Q3
Sell
-38,762
Closed -$1.77M 949
2018
Q2
$1.77M Sell
38,762
-10,712
-22% -$474K 0.04% 199
2018
Q1
$1.96M Sell
49,474
-3,499
-7% -$130K 0.04% 189
2017
Q4
$1.77M Sell
52,973
-1,505
-3% -$53.4K 0.04% 204
2017
Q3
$2.02M Buy
54,478
+32,930
+153% +$1.24M 0.05% 200
2017
Q2
$798K Buy
+21,548
New +$703K 0.02% 306

Other funds holding PAHC

O'Shaughnessy Asset Management's PAHC Position: Q4 2021 in Review

O'Shaughnessy Asset Management sold out of Phibro Animal Health (PAHC) in Q4 2021, closing a stake of 1,682 shares — an estimated $36K sold.

O'Shaughnessy Asset Management first reported a position in PAHC in Q2 2017 and held it in 8 quarters. The position peaked at $2.02M in Q3 2017. 145 funds tracked by Wall St. Rank hold PAHC as of Q4 2021.

  • O'Shaughnessy Asset Management reported no remaining Phibro Animal Health position as of Q4 2021 after selling out during the quarter.
  • O'Shaughnessy Asset Management sold 1,682 Phibro Animal Health shares in Q4 2021, an estimated $36K.
  • O'Shaughnessy Asset Management first reported a position in Phibro Animal Health in Q2 2017 and held it in 8 quarters.
  • O'Shaughnessy Asset Management's Phibro Animal Health position peaked at $2.02M in Q3 2017.
  • 145 funds tracked by Wall St. Rank held Phibro Animal Health as of Q4 2021.

Based on O'Shaughnessy Asset Management's 13F filing for Q4 2021, filed 11 Feb 2022.